SPG7 and amyotrophic lateral sclerosis: In line with these findings, there was a slight trend toward longer disease duration in SPG7 versus non-SPG7 variant carriers (Supplementary Table 3), suggesting that ALS patients with rare SPG7 variants may have a somewhat better prognosis than non-carriers.